Surrozen Future Growth
Future criteria checks 0/6
Surrozen's earnings are forecast to decline at 8.5% per annum. EPS is expected to grow by 61.3% per annum.
Key information
-8.5%
Earnings growth rate
61.3%
EPS growth rate
Biotechs earnings growth | 24.8% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 09 May 2024 |
Recent future growth updates
Recent updates
Will Surrozen (NASDAQ:SRZN) Spend Its Cash Wisely?
Jan 03Will Surrozen (NASDAQ:SRZN) Spend Its Cash Wisely?
Jun 19Here's Why Surrozen (NASDAQ:SRZN) Must Use Its Cash Wisely
Feb 12Surrozen stock rises ~13% premarket on licensing deal with Boehringer Ingelheim
Oct 06Surrozen GAAP EPS of -$0.40 beats by $0.06
Aug 11Surrozen CEO Craig Parker - Biotechs Can Never Be Too Well Capitalized (Video)
Oct 14Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | N/A | -43 | N/A | -33 | 2 |
12/31/2024 | N/A | -36 | N/A | -32 | 2 |
3/31/2024 | N/A | -38 | -35 | -35 | N/A |
12/31/2023 | N/A | -43 | -41 | -40 | N/A |
9/30/2023 | 13 | -35 | -34 | -33 | N/A |
6/30/2023 | 13 | -38 | -38 | -37 | N/A |
3/31/2023 | 13 | -42 | -41 | -40 | N/A |
12/31/2022 | 13 | -36 | -45 | -44 | N/A |
9/30/2022 | N/A | -50 | -56 | -55 | N/A |
6/30/2022 | N/A | -51 | -57 | -55 | N/A |
3/31/2022 | N/A | -50 | -58 | -57 | N/A |
12/31/2021 | N/A | -55 | -50 | -49 | N/A |
9/30/2021 | N/A | -51 | -48 | -47 | N/A |
6/30/2021 | N/A | -45 | -41 | -40 | N/A |
3/31/2021 | N/A | -39 | -35 | -33 | N/A |
12/31/2020 | N/A | -33 | -30 | -29 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SRZN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SRZN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SRZN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if SRZN's revenue is forecast to grow faster than the US market.
High Growth Revenue: SRZN is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SRZN's Return on Equity is forecast to be high in 3 years time